A randomized controlled trial of kalmegh supplementation on non-alcoholic fatty liver disease

被引：0
|
作者：
Nandekar, Sanket [1 ]
Kumar, Sunil [1 ]
Yadav, Devesh [2 ]
Sen, Binay [3 ]
Gadge, Pournima [4 ]
机构：
[1] Banaras Hindu Univ, Inst Med Sci, Dept Community Med, Varanasi, Uttar Pradesh, India
[2] Banaras Hindu Univ, Inst Med Sci, Dept Gastroenterol, Varanasi, Uttar Pradesh, India
[3] Banaras Hindu Univ, Inst Med Sci, Dept Dravyaguna, Varanasi, Uttar Pradesh, India
[4] Apex Inst Ayurved Med & Hosp, Dept Prasuti Tantra, Mirzapur, India
来源：
JOURNAL OF HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-530
引用
收藏
页码：S830 / S830
页数：1
相关论文
共 50 条
  • [31] Effect of aerobic exercise and resistance exercise in improving non-alcoholic fatty liver disease: a randomized controlled trial
    贾国瑜
    ChinaMedicalAbstracts(InternalMedicine), 2018, 35 (02) : 107 - 108
  • [32] Community-based lifestyle modification programme for non-alcoholic fatty liver disease: A randomized controlled trial
    Wong, Vincent Wai-Sun
    Chan, Ruth Suk-Mei
    Wong, Grace Lai-Hung
    Cheung, Bernice Ho-Ki
    Chu, Winnie Chiu-Wing
    Yeung, David Ka-Wai
    Chim, Angel Mei-Ling
    Lai, Jennifer Wing-Yan
    Li, Liz Sin
    Sea, Mandy Man-Mei
    Chan, Francis Ka-Leung
    Sung, Joseph Jao-Yiu
    Woo, Jean
    Chan, Henry Lik-Yuen
    JOURNAL OF HEPATOLOGY, 2013, 59 (03) : 536 - 542
  • [33] Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol
    Jennifer E. Lambert
    Jill A. Parnell
    Bertus Eksteen
    Maitreyi Raman
    Marc R. Bomhof
    Kevin P. Rioux
    Karen L. Madsen
    Raylene A. Reimer
    BMC Gastroenterology, 15
  • [34] Effects of the 5:2 intermittent fasting diet on non-alcoholic fatty liver disease: A randomized controlled trial
    Varkaneh, Hamed Kord
    Sahlabadi, Ammar Salehi
    Gaman, Mihnea-Alexandru
    Rajabnia, Mohsen
    Macit-Celebi, Melahat Sedanur
    Santos, Heitor O.
    Hekmatdoost, Azita
    FRONTIERS IN NUTRITION, 2022, 9
  • [35] The efficacy of flaxseed and hesperidin on non-alcoholic fatty liver disease: an open-labeled randomized controlled trial
    Zahra Yari
    Makan Cheraghpour
    Seyed Moayed Alavian
    Mehdi Hedayati
    Hassan Eini-Zinab
    Azita Hekmatdoost
    European Journal of Clinical Nutrition, 2021, 75 : 99 - 111
  • [36] The efficacy of flaxseed and hesperidin on non-alcoholic fatty liver disease: an open-labeled randomized controlled trial
    Yari, Zahra
    Cheraghpour, Makan
    Alavian, Seyed Moayed
    Hedayati, Mehdi
    Eini-Zinab, Hassan
    Hekmatdoost, Azita
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2021, 75 (01) : 99 - 111
  • [37] Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol
    Lambert, Jennifer E.
    Parnell, Jill A.
    Eksteen, Bertus
    Raman, Maitreyi
    Bomhof, Marc R.
    Rioux, Kevin P.
    Madsen, Karen L.
    Reimer, Raylene A.
    BMC GASTROENTEROLOGY, 2015, 15
  • [38] The efficacy of silymarin in decreasing transaminase activities in non-alcoholic fatty liver disease: A randomized controlled clinical trial
    Hajaghamohammadi, Ali-Akbar
    Ziaee, Amir
    Rafiei, Ramin
    HEPATITIS MONTHLY, 2008, 8 (03) : 191 - 195
  • [39] Effects of Green Coffee Bean Extract Supplementation on Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial
    Shahmohammadi, Hedayat Allah
    Hosseini, Seyed Ahmad
    Hajiani, Eskandar
    Malehi, Amal Saki
    Alipour, Meysam
    HEPATITIS MONTHLY, 2017, 17 (04)
  • [40] Omega-3 fatty acids for treatment of non-alcoholic fatty liver disease: design and rationale of randomized controlled trial
    Wojciech Janczyk
    Piotr Socha
    Dariusz Lebensztejn
    Aldona Wierzbicka
    Artur Mazur
    Joanna Neuhoff-Murawska
    Pawel Matusik
    BMC Pediatrics, 13
12345